Biotron pioneer dies

By Ruth Beran
Tuesday, 16 August, 2005

Peter Gage, an internationally recognised pioneer of the use of ion channels as a treatment for viral diseases, died on August 13 after a long illness.

A professor of physiology at Australian National University's John Curtin School of Medical Research, Gage's research formed the basis of Canberra biotech company Biotron's (ASX:BIT) Virion project, an antiviral treatment nearing commercialisation for the treatment of a range of viruses including HIV and hepatitis C.

Cartherics and Catalent announce enhanced partnership

To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...

Alliance seeks to boost regional capacity in clinical trials

Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...

Lipid science receives new Australia-led online hub

The Lipid Network launched this month to build links between researchers, clinicians and industry...

Content from other channels on our network

NSW Government opens RNA Research and Manufacturing Facility

Siemens launches purpose‍-‍built AI agent for automation engineering

EtherCAT certified cybersecure to IEC 62443

WA Government extends support for lithium industry

Manufacturing-friendly plastic surface destroys viruses on contact

Support at Home showering reclassified as 'clinical care' as part of $3bn investment

Victoria announces "massive" upgrade to one of its busiest hospitals

NSW IRC decision prompts "mixed emotions" from nurses and midwives

Surgical robot expands its scope of procedures

Neuroscientists propose clinical definition for brain fog in menopause

Digital water treatment — real-time data for safe and efficient processes

Key insights from first mandatory sustainability reporting

Vessev launches an electric hydrofoiling network in Tas

Office tower cuts HVAC energy use by nearly 50%

Climate Tech Partners backs Australian battery recycling